In a patient with essential tremor currently taking lorazepam and buspirone, what additional pharmacologic or procedural therapies can be used that avoid further central nervous system depression and drug interactions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Treatment Options for Essential Tremor Beyond Benzodiazepines and Buspirone

First-Line Pharmacologic Alternatives

For a patient with essential tremor currently on lorazepam and buspirone who needs additional tremor control without further CNS depression, propranolol or primidone should be initiated as first-line therapy, as these agents are effective in up to 70% of patients and represent the standard of care. 1

Propranolol

  • Start propranolol at 60 mg daily in divided doses, titrating up to 120-320 mg daily based on tremor response 2, 3
  • Propranolol provides sustained tremor control and can be used either continuously for persistent disability or intermittently for stress-related tremor exacerbations 3
  • Contraindications include chronic obstructive pulmonary disease, asthma, heart block, and bradycardia—screen carefully before initiating 1
  • If propranolol causes intolerable side effects, alternative beta-blockers such as atenolol or metoprolol may be substituted, though they have slightly lower efficacy 2, 4

Primidone

  • Initiate primidone at 12.5-25 mg at bedtime to minimize acute toxic reaction (confusion, nausea, ataxia), then increase by 25-50 mg every week to a target of 62.5-750 mg daily 2, 3
  • Primidone provides comparable efficacy to propranolol and can be combined with propranolol if monotherapy fails 2, 4
  • Caution: primidone has abuse potential, which is particularly relevant given this patient's current benzodiazepine use 5

Second-Line Pharmacologic Options

Topiramate

  • Consider topiramate 25-400 mg daily if propranolol and primidone fail or are contraindicated 2, 6, 4
  • Topiramate avoids CNS depression and has no abuse potential 4
  • Titrate slowly (25 mg increments weekly) to minimize cognitive side effects and paresthesias 4

Gabapentin

  • Gabapentin 300-3600 mg daily in divided doses represents another second-line option without significant CNS depression 2, 6, 4
  • Gabapentin has a favorable tolerability profile and no abuse liability 4
  • May be particularly useful if the patient has comorbid neuropathic pain 4

Other Anticonvulsants

  • Levetiracetam and zonisamide have emerging evidence for essential tremor control 6
  • Oxcarbazepine showed significant tremor improvement in case reports and offers advantages including good tolerability, extended half-life, and lack of abuse potential 5

Procedural/Surgical Therapies

MRI-Guided Focused Ultrasound (MRgFUS) Thalamotomy

MRgFUS thalamotomy should be considered for medication-refractory essential tremor, as it provides 53-56% tremor improvement sustained at 2-4 years with no incisions, no hardware, and minimal serious adverse events (1.6%). 1

Patient Selection Criteria

  • Diagnosis of moderate-to-severe essential tremor causing significant functional disability despite optimal medical therapy 1
  • Age ≥22 years 1
  • Skull density ratio ≥0.40 (required for adequate ultrasound penetration) 1
  • Able to undergo MRI without contraindications 1

Efficacy and Safety Profile

  • Tremor scores improved by 53% at 1 year and 56% at 2 years, with sustained disability improvements 1
  • Early adverse effects (gait disturbance 36%, paresthesias 38%) largely resolve by 1 year (9% and 14% respectively) 1
  • No hemorrhage or infection risk, unlike open surgical procedures 1
  • Most adverse events are mild-to-moderate (98.4%), with serious adverse events rare (1.6%) 1

Deep Brain Stimulation (DBS) and Other Surgical Options

  • DBS of the ventral intermediate nucleus (VIM) of the thalamus provides tremor control in approximately 90% of patients 2, 6
  • DBS has comparable efficacy to radiofrequency thalamotomy but with fewer complications, particularly for bilateral procedures 2
  • Surgical options should be reserved for severe, medication-refractory tremor causing significant functional impairment 1, 2

Botulinum Toxin Injections

  • Botulinum toxin injections are effective for disabling head or voice tremor 2, 6
  • Particularly useful for wrist flexion/extension tremor patterns 6
  • Avoid botulinum toxin in hand muscles due to bothersome hand weakness 2

Critical Treatment Algorithm

  1. Verify adequate trials of current medications: Ensure lorazepam and buspirone have been optimized before adding agents 3
  2. Initiate propranolol or primidone as first-line add-on therapy (choose based on comorbidities and contraindications) 1, 2
  3. If monotherapy with propranolol or primidone inadequate, combine both agents 2, 4
  4. If combination propranolol + primidone fails, add topiramate or gabapentin 2, 6, 4
  5. Consider MRgFUS thalamotomy or DBS for medication-refractory cases with significant functional disability 1, 2

Important Caveats

  • Gradually taper and discontinue lorazepam to avoid benzodiazepine dependence and CNS depression, particularly before adding other agents 1
  • Avoid combining multiple CNS depressants (benzodiazepines, alcohol, sedating anticonvulsants) due to quadrupled overdose death risk 1
  • Ethanol provides temporary tremor relief but should not be recommended due to abuse potential and social consequences 6, 3
  • Approximately 50% of patients achieve adequate tremor control with medications alone; surgical options dramatically improve function in medication-refractory cases 1, 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Medical treatment of essential tremor.

Journal of central nervous system disease, 2014

Research

Oxcarbazepine use in essential tremor.

The Annals of pharmacotherapy, 2006

Research

Essential tremor: treatment options.

Current treatment options in neurology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.